Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

dc.contributor.author	Landstrom, AP
dc.contributor.author	Ackerman, MJ
dc.date.accessioned	2020-04-01T13:45:54Z
dc.date.available	2020-04-01T13:45:54Z
dc.date.issued	2010-12
dc.date.updated	2020-04-01T13:45:53Z
dc.identifier	122/23/2441
dc.identifier.issn	0009-7322
dc.identifier.issn	1524-4539
dc.identifier.uri	https://hdl.handle.net/10161/20332
dc.language	eng
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	Circulation
dc.relation.isversionof	10.1161/CIRCULATIONAHA.110.954446
dc.subject	Humans
dc.subject	Cardiomyopathy, Hypertrophic
dc.subject	Prognosis
dc.subject	Predictive Value of Tests
dc.subject	Genotype
dc.subject	Mutation
dc.title	Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
dc.type	Journal article
duke.contributor.orcid	Landstrom, AP\|0000-0002-1878-9631
pubs.begin-page	2441
pubs.end-page	2450
pubs.issue	23
pubs.organisational-group	School of Medicine
pubs.organisational-group	Cell Biology
pubs.organisational-group	Pediatrics, Cardiology
pubs.organisational-group	Duke
pubs.organisational-group	Basic Science Departments
pubs.organisational-group	Pediatrics
pubs.organisational-group	Clinical Science Departments
pubs.publication-status	Published
pubs.volume	122

Files

Now showing 1 - 1 of 1